Efficacy and safety of low-dose TBI combined MAC regimen for HSCT in high-risk AML patients with active disease
Background The management of high-risk acute myeloid leukaemia (AML) remains challenging, highlighting the need for innovative conditioning strategies beyond current regimens.Methods In the present single-arm study, a FACT regimen comprised of low-dose total body irradiation (TBI) with fludarabine,...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2024.2446692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|